CareDx, Inc. Email Format
Biotechnology ResearchCalifornia, United States501-1000 Employees
CareDx, Inc. is a biotechnology research company that concentrates on precision medicine for transplant care. It pursues the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and their caregivers. Headquartered in South San Francisco, California, the company operates within the biotechnology sector and aims to improve transplant outcomes through its portfolio of solutions. Its customers are transplant patients and their caregivers, and its work serves the transplant care ecosystem. In April 2026, CareDx announced an agreement to acquire Naveris, a leader in viral-mediated cancer MRD surveillance testing.